COVID-19 in Patients with Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization.

Hossein AziziHanie KarimiMahdi KazemiSomaye Sadat RezaeiAmirhossein ParsaeiMohammad AghaaliJamshid VafaeimaneshPouya TorabiBehnam AminiMaryam Masoumi

Published in: Rheumatology and therapy (2022)

This study found that advanced age and comorbidities, similar to the general population, are risk factors for hospitalization in patients with COVID-19 with rheumatic disorders. Administration of csDMARDs, older age, and pulmonary disorders were linked to increased risk of COVID-19 pneumonia in these individuals.

Keyphrases

coronavirus disease
sars cov
rheumatoid arthritis
high resolution
pulmonary hypertension
physical activity
respiratory syndrome coronavirus
middle aged
community dwelling
fluorescence imaging